Concepedia

Publication | Open Access

Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment

39

Citations

27

References

2020

Year

Abstract

These novel preclinical data support initiation of a first-in-human clinical trial with this combination immunotherapy strategy in pancreatic cancer.

References

YearCitations

Page 1